Pricing Log in Create free account

SeaStar Medical Holding Corporation (ICU) vs Pasithea Therapeutics Corp. (KTTA)

SeaStar Medical Holding Corporation and Pasithea Therapeutics Corp. are both Biotechnology companies. SeaStar Medical Holding Corporation and Pasithea Therapeutics Corp. are of similar size ($13.7M and $13.5M). Pasithea Therapeutics Corp. has the higher net margin (0.00% vs −795.5%) and the lower return on invested capital (−367.5% vs 0.00%). Across the 15 metrics below, Pasithea Therapeutics Corp. leads on 8 and SeaStar Medical Holding Corporation on 7.

Valuation

Metric ICU KTTA Biotechnology median
P/E n/m n/m 8.50
P/S 6.99 27.71 9.71
P/B 2.79 0.27 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m 1.39 0.64
EV/Sales 4.42 (66.34) 9.21
Earnings yield (133.45%) (376.19%) (33.15%)
Free cash flow yield (114.43%) (130.85%) (25.50%)

Profitability

Metric ICU KTTA Biotechnology median
Gross margin 92.64% 0.00% 65.16%
Operating margin (816.75%) 0.00% 0.00%
Net margin (795.50%) 0.00% 0.00%
Free cash flow margin (799.36%) 0.00% 0.00%
Return on equity (356.87%) (65.49%) (56.36%)
Return on assets (160.02%) (61.97%) (48.04%)
Return on invested capital 0.00% (367.46%) 0.00%

Growth

Metric ICU KTTA Biotechnology median
Revenue growth (TTM) 123.63% — 6.02%
EPS growth (last fiscal year) 91.16% 77.07% 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ICU KTTA Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 1.89 26.25 4.72
Net debt to EBITDA 0.99 2.74 0.96

Dividend

Metric ICU KTTA Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric ICU KTTA Biotechnology median
Market cap 13.48m 13.70m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack